-
公开(公告)号：US20190151640A1
公开(公告)日：2019-05-23
申请号：US16196934
申请日：2018-11-20
Applicant: Boston Scientific Scimed, Inc.
Inventor： Jan Weber , Keith R. Maile , Deepa Mahajan , Jeffrey E. Stahmann , James M. Peck
Abstract: A system for monitoring one or more respiratory conditions is disclosed. The system comprises a medical device and an e-tattoo configured to attach to the subject's skin. The medical device is configured to monitor at least one respiratory parameter of a subject and transmit a signal in response to monitoring a trigger event in the at least one respiratory parameter. The e-tattoo is configured to: receive the signal from the medical device; sense at least one environmental parameter in response to receiving the signal; and transmit the at least one environmental parameter.
-
公开(公告)号：US20240024670A1
公开(公告)日：2024-01-25
申请号：US18227021
申请日：2023-07-27
Applicant: Boston Scientific Scimed, Inc.
Inventor： Brian L. Schmidt , Benjamin Keith Stein , Keith R. Maile , William J. Linder , Aleksandra Kharam
CPC classification number: A61N1/36002 , A61F7/007 , A61F2007/0073 , A61F2007/0096
Abstract: Embodiments herein relate to medical devices and methods for using the same to treat cancerous tumors within a bodily tissue. A medical device system is included having an electric field generating circuit configured to generate one or more electric fields and a control circuit in communication with the electric field generating circuit. The control circuit configured to control delivery of the one or more electric fields from the electric field generating circuit. The system can include two or more electrodes to deliver the electric fields to a site of a cancerous tumor within a patient and a temperature sensor to measure the temperature of tissue at the site of the cancerous tumor. The control circuit can cause the electric field generating circuit to generate one or more electric fields at frequencies selected from a range of between 10 kHz to 1 MHz. Other embodiments are also included herein.
-
公开(公告)号：US11850422B2
公开(公告)日：2023-12-26
申请号：US16855433
申请日：2020-04-22
Applicant: Boston Scientific Scimed, Inc.
Inventor： Brian L Schmidt , Devon N. Arnholt , Keith R. Maile , Sarah Melissa Gruba , William J. Linder
CPC classification number: A61N1/36002 , A61L31/16 , A61N1/05 , A61N1/08
Abstract: Embodiments herein relate to medical devices and methods for using the same to treat cancerous tumors within a bodily tissue. A medical device system is included having an electric field generating circuit and control circuitry configured to control delivery of the one or more electric fields from the electric field generating circuit to the site of the cancerous tissue. An implantable lead is included having a lead body including a first electrical conductor disposed within the lead body, and a first electrode coupled to the lead body, the first electrode in electrical communication with the first electrical conductor, wherein the first electrical conductor forms part of an electrical circuit by which the electric fields from the electric field generating circuit are delivered to the site of the cancerous tissue, and the first electrode can include a conductive coil filar disposed around the lead body. Other embodiments are also included herein.
-
公开(公告)号：US11607542B2
公开(公告)日：2023-03-21
申请号：US16855421
申请日：2020-04-22
Applicant: Boston Scientific Scimed, Inc.
Inventor： Brian L. Schmidt , Devon N. Arnholt , Benjamin Keith Stein , Keith R. Maile , William J. Linder , Ron A. Balczewski , Jacob M. Ludwig , Aleksandra Kharam
Abstract: Embodiments herein relate to medical devices and methods for using the same to treat cancerous tumors within a bodily tissue. A medical device system is included having at least one electric field generating circuit configured to generate one or more electric fields; control circuitry in communication with the electric field generating circuit, the control circuitry configured to control delivery of the one or more electric fields from the at least one electric field generating circuit; and two or more electrodes to deliver the electric fields to the site of a cancerous tumor within a patient. At least one electrode can be configured to be implanted. At least one electrode can be configured to be external. The control circuitry can cause the electric field generating circuit to generate one or more electric fields at frequencies selected from a range of between 10 kHz to 1 MHz.
-
Patent Agency Ranking
公开(公告)号：US20220240856A1
公开(公告)日：2022-08-04
申请号：US17591101
申请日：2022-02-02
Applicant: BOSTON SCIENTIFIC SCIMED, INC.
Inventor： Jeffrey E. Stahmann , Bin Mi , Keith R. Maile
IPC: A61B5/00 , A61B5/0215 , A61F2/24
Abstract: A medical system for monitoring a left atrial pressure in a heart of a patient may include an implantable device including an expandable framework and a first sensor secured to the expandable framework and an external component configured to communicate wirelessly with the implantable device. The first sensor may be configured to detect a first measurement. The first sensor may be a pressure sensor and the first measurement may be the left atrial pressure. The implantable device or the external component may include a processor configured to create a first trend for the first measurement. The processor may be configured to use the first trend to modify the first measurement prior to outputting a corrected result.
-
公开(公告)号：US20200338345A1
公开(公告)日：2020-10-29
申请号：US16855433
申请日：2020-04-22
Applicant: Boston Scientific Scimed, Inc.
Inventor： Brian L. Schmidt , Devon N. Arnholt , Keith R. Maile , Sarah Melissa Gruba , William J. Linder
Abstract: Embodiments herein relate to medical devices and methods for using the same to treat cancerous tumors within a bodily tissue. A medical device system is included having an electric field generating circuit and control circuitry configured to control delivery of the one or more electric fields from the electric field generating circuit to the site of the cancerous tissue. An implantable lead is included having a lead body including a first electrical conductor disposed within the lead body, and a first electrode coupled to the lead body, the first electrode in electrical communication with the first electrical conductor, wherein the first electrical conductor forms part of an electrical circuit by which the electric fields from the electric field generating circuit are delivered to the site of the cancerous tissue, and the first electrode can include a conductive coil filar disposed around the lead body. Other embodiments are also included herein.
-
公开(公告)号：US20200330758A1
公开(公告)日：2020-10-22
申请号：US16850728
申请日：2020-04-16
Applicant: Boston Scientific Scimed, Inc.
Inventor： Brian L. Schmidt , Benjamin Keith Stein , Keith R. Maile , Ron A. Balczewski , Aleksandra Kharam
Abstract: Embodiments herein relate to a method for treating a cancerous tumor located within a subject. The method can include applying one or more electric fields at or near a site of the cancerous tumor, where the cancerous tumor can include a cancerous cell population. The one or more applied electric fields are effective to delay mitosis and cause mitotic synchronization within a proportion of the cancerous cell population. The method can include removing the one or more electric fields to allow mitosis to proceed within the cancerous cell population. The method can include administering a chemotherapeutic agent to the subject after the one or more electric fields have been removed. Other embodiments are also included herein.
-
公开(公告)号：US12186553B2
公开(公告)日：2025-01-07
申请号：US18123776
申请日：2023-03-20
Applicant: Boston Scientific Scimed, Inc.
Inventor： Brian L. Schmidt , Devon N. Arnholt , Benjamin Keith Stein , Keith R. Maile , William J. Linder , Ron A. Balczewski , Jacob M. Ludwig , Aleksandra Kharam
Abstract: Embodiments herein relate to medical devices and methods for using the same to treat cancerous tumors within a bodily tissue. A medical device system is included having at least one electric field generating circuit configured to generate one or more electric fields; control circuitry in communication with the electric field generating circuit, the control circuitry configured to control delivery of the one or more electric fields from the at least one electric field generating circuit; and two or more electrodes to deliver the electric fields to the site of a cancerous tumor within a patient. At least one electrode can be configured to be implanted. At least one electrode can be configured to be external. The control circuitry can cause the electric field generating circuit to generate one or more electric fields at frequencies selected from a range of between 10 kHz to 1 MHz.
-
公开(公告)号：US20220304807A1
公开(公告)日：2022-09-29
申请号：US17655937
申请日：2022-03-22
Applicant: Boston Scientific Scimed, Inc.
Inventor： Noel Smith , Keith R. Maile , Thomas Andrew Albrecht , Daragh Nolan , Brian P. Watschke , Thomas Sinnott , Richard Percy , Bryan Duane Johnson , Laurence Norris , John Gildea , Eduardo Marcos Larangeira
Abstract: An implantable fluid operated device may include a fluid reservoir configured to hold fluid, an inflatable member, and a pump assembly configured to transfer fluid between the fluid reservoir and the inflatable member. The pump assembly may include one or more fluid pumps and one or more valves. One or more sensing devices may be positioned within fluid passageways of the fluid operated device. The electronic control system may control operation of the pump assembly based on fluid pressure measurements and/or fluid flow measurements received from the one or more sensing devices. The pump assembly may include a piezoelectric pump. The one or more sensing devices may include one or more pressure transducers positioned in the fluid passageways, one or more strain gauges measuring deflection of piezoelectric elements, voltage input/output at one or more piezoelectric elements, and other types of sensing devices.
-
-
-
-
-
-
-
-
Search Results
29
records
(took 0.027 seconds)
